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ABSTRACT: Seven tetra-coordinate organoboron fluorophores with hetero-biaryl N,O or N,N chelate ligands were prepared and 
photophysically characterized. The electronic variation of the heteroaromatic moiety provided a means for the fine-tuning of the 
UV/vis-absorption and emission spectra. In the most interesting cases the spectra were re-shifted to maximum absorbance at wave-
lengths above 500 nm and emission maxima between 620 and 660 nm. The pronounced intramolecular charge-transfer character of 
the dyes yielded large Stokes shifts (3400–5100 cm
–1
), while maintaining appreciable fluorescence quantum yields of up to 0.2 for 
emission maxima at above 600 nm. The lipophilic character of the dyes enabled their application as stains of vesicle substructures 
in confocal fluorescence microscopy imaging.   
INTRODUCTION 
The molecular design of fluorescent organoboron architectures 
has received renewed impulse from their demonstrated utility in 
optoelectronic applications,1-3 as sensors and switches,4-7 or in 
bioimaging.8-10 Especially tetracoordinate boron(III) compounds 
with bidentate chelating ligands have been in the focus of these 
efforts.11-13 The coordinative saturation of the boron center con-
fers increased chemical stability and rigidity, often accompanied 
by significantly high fluorescence quantum yields. Par excellence 
examples for boron(III) dyes with widespread application in 
chemical biology and sensing are Bodipy dyes.4,8,14-19 The fluo-
rescence emission of these compounds can be fine-tuned by ma-
nipulation of the substitution pattern, extension of the π-conjugate 
system, or heteroatom substitution in the chromophore skeleton, 
among other strategies.20 Examples for such designs are electron-
donor-substituted styryl Bodipy dyes21 and aza-Bodipy dyes.22-24 
Modifications of the chromophore skeleton also have been proven 
to lead to pronounced red shifts of the emission in the case of 
xanthene dyes, leading for example to sila- or carbo-derivatives of 
fluoresceins or rhodamines.25-27 The extension of the π-
conjugation of the chromophore, such as in naphthofluoresceins28 
or cyanine dyes,29,30 is an often applied recipe for achieving emis-
sion in the red or even near-infrared (NIR) spectral region.9 
Fluorophores with red-shifted absorption and emission spectra are 
of particular interest in bioimaging, because problems of the 
penetration depth of excitation light and re-absorption of emitted 
light by the biological tissue are widely avoided. 
 
Chart 1. Structures and general photophysical properties 
(in toluene) of arylisoquinoline-based organoboron che-
lates 
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Scheme 1. Synthesis of the dyes 11–17. 
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 In a recent work we have demonstrated the usefulness of 
arylisoquinoline-derived N,C ligands for the design of highly 
fluorescent compounds with applications in bioimaging (see 
Scheme 1).10 The photophysical characteristics of these com-
pounds are dominated by intramolecular charge-transfer (ICT) 
phenomena, providing large Stokes shifts and emissions that can 
be fine-tuned by electron-donor substitution and/or solvent ef-
fects. However, the most red-shifted emission of these fluoro-
phores was still below 600 nm. The desire to force the emission 
further towards the red spectral region triggered our efforts to 
synthesize related organoboron fluorophores with an aryli-
soquinoline skeleton or related N-heterocyclic ligands (see 
Scheme 1). 
 Additional O- or N-electron-donor substituents were integrat-
ed in the expectation of achieving energetically lower lying emis-
sive states. Thereby the above outlined strategies of electronic 
manipulations of the chromophore skeleton itself and its substitu-
tion pattern were synergistically combined. Interestingly, pro-
nounced red shifts of the absorption and fluorescence spectra were 
obtained for some of the prepared dyes, while maintaining appre-
ciable emission quantum yields of up to 0.2. The implication of 
ICT processes in the design of red-emitting fluorophores guaran-
tees the desired large Stokes shifts, but unfortunately often leads 
to very low emission quantum yields. This is a direct consequence 
of the energy-gap law, favoring non-radiative deactivation of 
energetically low-lying emissive states, but may find also at least 
partial explanation in efficient intersystem crossing to close-lying 
triplet states. Having this in mind, the herein reported quantum 
yields are very significant.  
 Finally, the hydrophobic nature and structural shape of these 
fluorophores led to the prediction of a preferential accumulation 
in non-polar cell compartments such as vesicle substructures,31 
which indeed was verified by confocal fluorescence microscopy 
imaging. 
 
RESULTS AND DISCUSSION 
 Synthesis of the Organoboron Dyes 11–17. The synthesis of 
the N,B,O-dyes 11–13 was carried out starting from the corre-
sponding alcohols 1–3, by reaction with BPh3 in anhydrous tolu-
ene at 90 C (Scheme 1). After heating overnight, the purification 
by conventional flash chromatography or precipitation afforded 
the dyes 11–13 in moderate to excellent yields (48–99%). A 
similar strategy was employed for the synthesis of the N,B,N-dyes 
14-17, where the starting amines 7–10 were accessible by a 
Buchwald-Hartwig coupling reaction32,33 between the nonaflates 
4–6 and the corresponding aniline. The dyes 14–17 were obtained 
in moderate to excellent yields of 39–94% (see Supporting Infor-
mation for more details). The identity and purity of the dyes was 
established by 1H, 13C, and 11B NMR spectroscopy, as well as 
high-resolution electrospray mass spectrometry. 
Figure 1. UV/vis absorption spectra (solid lines) and fluorescence 
spectra (dashed lines) of the compounds 11 (black), 13 (blue), 14 
(green), and 15 (red) in aerated toluene. 
 Photophysical Properties. The UV/vis absorption and fluo-
rescence properties of toluene solutions of the herein prepared 
dyes are summarized in Table 1 and representative spectra are 
shown in Figure 1. The absorption spectral properties show a clear 
dependence on the heterobiaryl skeleton (arylisoquinolines 11, 14; 
arylquinazolines 12, 15; arylphthalazines 13, 16) for both the 
N,B,O- and the N,B,N-dye series. In each series the arylquinazo-
 line dyes show the most red-shifted long-wavelength absorption 
maximum. Furthermore, generally the N,B,N-dyes have more red-
shifted absorption (above 500 nm) and emission maxima than the 
N,B,O-dyes, extending to red emission color. The dyes show 
increased Stokes shifts, varying between 3400 and 5100 cm–1. The 
fluorescence quantum yields follow clearly the energy-gap law in 
photochemistry: non-radiative deactivation pathways become 
more competitive for energetically lower lying emissive states. 
Hence, the fluorescence quantum yields drop for the N,B,N-dyes, 
although maintaining still quite appreciable levels considering that 
these dyes feature emission maxima above 600 nm, e.g., Φfluo = 
0.17 for dye 14. The introduction of additional electron-donor 
substitution (i.e., a methoxy group in dye 17) shifts the absorption 
and fluorescence maxima somewhat further to the red, but mainly 
lead to a very accentuated drop of the emission quantum yield, 
again a direct consequence of the energy-gap law. The fluores-
cence lifetimes were measured as being around 9.5 ns for the 
N,B,O-dyes and are more variable (0.25–6.31 ns) for the N,B,N-
dyes. 
 
Figure 2. Fluorescence spectra of dye 15 in n-hexane (black), toluene 
(blue), chloroform (green), and N,N-dimethylformamide (red). The 
spectra are normalized to show the relative emission quantum yields 
in the different solvents. The inset shows the Lippert-Mataga plot (n = 
9, r
2
 = 0.9323) for dye 15; see text.  
 In order to obtain further insights into the nature of the ob-
served fluorescence the solvent effect was studied for selected 
N,B,N-dyes. Note that the N,B,O-dyes show insufficient chemical 
stability in solvents such as tetrahydrofuran, N,N-
dimethylformamide and sometimes in acetonitrile. The N,B,N-
dyes show a hypsochromic shift (negative solvatochromism) on 
changing from non-polar toluene to polar acetonitrile, while the 
emission bands shift bathochromically (positive solvatochrom-
ism). As a result the Stokes shift is increased in acetonitrile. This 
effect is most accentuated for the dyes 15 and 16 for which nota-
ble Stokes shifts of 4500 cm–1 and 5100 cm–1, respectively, were 
observed. However, expectedly this comes at the expense of a 
drastically reduced emission quantum yield for these two dyes, 
being lower than 0.01 in acetonitrile. In order to establish a more 
detailed trend a series of nine different solvents, addressing as-
pects such as polarity, hydrogen bonding character, and viscosity, 
was studied for dye 15 (Figure 2 and detailed data in Supporting 
Information). 
Table 1. Photophysical properties of N,B,O-dyes 11–13 and 
N,B,N-dyes 14–17 in aerated toluene solution. 
dye λabs,max (nm) 
[ε (M–1cm–1)] 
λfluo,max (nm) 
 
Φfluo τfluo (ns) 
11 427 [5000] 522 0.32 9.47 
12 451 [5100] 543 0.25 9.59 
13 436 [3400] 556 0.15 9.32 
14 511 [6300] 623 0.17 6.31 
15 539 [8600] 656 0.03 1.56 
16 524 [2900] 657 0.05 2.56 
17 520 [6700] 643 <0.01 0.25 
 
  Beside the abovementioned positive solvatochromism of the 
emission spectrum, the following general trends can be derived: 
(a) protic solvents deactivate the fluorescence practically totally 
(Φfluo < 10
–3 in methanol), (b) in non-polar solvents the highest 
fluorescence quantum yields are observed (λmax, fluo = 641 nm, 
Φfluo = 0.06 in n-hexane), (c) increasing viscosity has no influence 
on the fluorescence (λmax, fluo = 642 nm, Φfluo = 0.07 in decalin). 
The treatment of the data according to the Lippert-Mataga equa-
tion34-36 yielded a dipole moment change (Δ) between ground 
and excited state of 10 Debye; see Supporting Information. This 
suggests an accentuated intramolecular charge-transfer (ICT) 
character of the emissive state and is in line with our recent results 
on N,C chelate tetra-coordinate arylisoquinoline organoboron 
compounds.10 The ICT character explains the observed large 
Stokes shifts (see above). 
 
Figure 3. HOMO/LUMO isosurface plots and frontier-orbital ener-
gies of the dyes 11 and 15. 
 The occurrence of ICT was confirmed by time-dependent 
density-functional theory calculations37 (CAM-B3LYP/6-
311+G(2d,p) level of theory) of 11, 14, 15, and 16 as representa-
tive dyes (see Supporting Information). The lowest-energy emis-
sion (S1→S0) corresponds mainly to a LUMO→HOMO transition 
(contribution of 95–97%). The contour plots of the frontier orbit-
als show that the HOMO is mainly located on the naphthyl-
derived "half" of the system, while the LUMO has its main con-
tribution from the heteroaromatic moiety; see Figure 3 for the 
examples of dye 11 and 15. The natural transition orbital (NTO) 
analysis yielded the same conclusion of an effective ICT process 
on excitation of the dyes. This observation resembles similar 
 results that were obtained for related borylated arylisoquinoline 
(BAI) dyes.10,38 
 Bioimaging Applications. The negligible fluorescence in 
protic media as contrasted by the significant fluorescence in non-
polar environments prompted us to investigate the use of the 
lipophilic organoboron N,N-chelates as probes for cellular lipid 
substructures such as vesicles.31,39,40 For this purpose the dyes 15 
and 16 were incubated with N13 mouse microglial cells. In a first 
approach viability studies were performed applying a flow cytom-
etry method using simultaneous Hoechst 33342 and propidium 
iodide staining.41 This yielded a cell viability rate of 83% follow-
ing 24 hours of incubation for both dyes at a concentration of 10 
M. These data were confirmed by high-throughput screening 
with automated microscopy using the same nuclear stains: 86% 
viability for 15 and 88% for 16 after 24 hours incubation. 
 
Figure 4. Confocal fluorescence microscopy images (left) of N13 
mouse microglial cells incubated (for 24 h) with dye 15 (10 M) – 
red. The submembrane actin (green) was stained with Atto488-
conjugated Phalloidin (0.1 M) and the nucleus (blue) with Hoechst 
33342 (8 M). The transmission microscopy images are shown on the 
right side. Scale bars: 10 m. 
 
Figure 5. Confocal fluorescence microscopy images of N13 mouse 
microglial cells. On the left the labeling with dye 15 (upper row) and 
16 (lower row), both at 30 M, is shown. The middle images show 
the corresponding labeling with the lipophilic probe FM4-64 and the 
overlay is shown on the right. 
 In Figure 4 images of N13 cells stained with dye 15, Hoechst 
33342 as marker of the cell nucleus, and Atto488-conjugated 
Phalloidin as marker for submembrane actin are shown. For many 
organic fluorophores a homogeneous cytoplasmic accumulation is 
typical, while for our dyes just a very weak "cloud-like" fluores-
cence was evident. This is in accordance with the strongly deac-
tivated fluorescence of the dye in polar (protic) media. However, 
a clear light-up behavior for the dye accumulation in some small 
intracellular substructures was observed. Having in mind the 
considerably higher fluorescence in non-polar environments, this 
is interpreted as the accumulation in vesicle-like substructures. 
Co-localization imaging (Figure 5) demonstrated the specific 
accumulation of the investigated dyes 15 and 16 in structures that 
are also marked by the liphophilic styryl dye FM4-64.42,43 
CONCLUSIONS 
 In summary, lipophilic tetracoordinate N,O- and N,N-chelate 
organoboron dyes show distinct photophysical properties that 
enable their application as vesicle stains in confocal fluorescence 
microscopy imaging. On the one hand, the N,O-chelates show 
green-to-yellow emission with quantum yields of up to 0.3. On 
the other hand, the N,N-chelates are characterized by fluorescence 
emission maxima above 600 nm, maintaining significant fluores-
cence quantum yields (up to 0.2). The emission quantum yields in 
the N,B,N series are generally lower than in the N,B,O series, 
being a direct consequence of the energy gap law and more domi-
nant nonradiative deactivation pathways. The large Stokes shifts 
of 3400–5100 cm–1, typical for the herein verified intramolecular 
charge-transfer phenomena, and the pronounced solvent-
dependence of the emission (especially of the N,B,N dyes) are 
additional attributes of the functional characteristics. 
EXPERIMENTAL SECTION 
 General Methods. 
1
H NMR spectra were recorded at 400 or 500 
MHz; 
13
C NMR spectra were recorded at 100 or 125 MHz with the 
solvent peak used as the internal reference (7.26 and 77.0 ppm for 
1
H 
and 
13
C, respectively). 11B NMR spectra were recorded with complete 
proton decoupling at 128 MHz using BF3·Et2O (0.00 ppm for 
11
B-
NMR) as an external standard. Column chromatography was per-
formed on silica gel. Analytical TLC was performed on aluminium 
backed plates (1.5  5 cm) pre-coated (0.25 mm) with silica gel. 
Compounds were visualized by exposure to UV light or by dipping 
the plates in a solution of 5% (NH4)2Mo7O24⋅4H2O in 95% EtOH 
(w/v) or followed by heating.  
 Anhydrous 1,4-dioxane and THF were obtained by distillation 
from sodium using benzophenone as indicator. Pd(dba)2, BPh3, 
BINAP ligand, aniline, and p-anisidine were commercially available. 
The alcohols 1-2 and the nonaflate 4 were synthesized according to 
literature procedures and their NMR spectra were found to resemble 
the published data.
44-46
 
 The solvents for the photophysical measurements were of spec-
troscopic quality and used as received. 
 Compound 3. A flamed-dried Schlenk tube was charged with 
Pd(PPh3)4 (5 mol%) and 1-chlorophthalazine (9.11 mmol, 1.5 g), and 
after three cycles of vacuum-argon flushing, DME (18 mL) was added 
and reaction mixture was stirred for 30 min at room temperature. (2-
Methoxynaphthalen-1-yl)boronic acid (1.2 eq.) and 11 mL of Na2CO3 
(2M, aq.) were then sequentially added and the reaction mixture was 
refluxed overnight, then cooled to room temperature, quenched with 
H2O (10 mL), and extracted with CH2Cl2 (3  20 mL). The organic 
layer was dried over anhydrous MgSO4, filtered, concentrated, and the 
residue was purified by flash chromatography on silica gel (EtOAc/n-
hexane 2:1 Et3N 1%) to afford 1-(2-methoxynaphthalen-1-
yl)phthalazine (1.62 g, 62%) as a light brown foam. 
1
H NMR (500 
MHz, CDCl3):  9.65 (d, 1H, J = 0.6 Hz), 8.06 (d, 2H, J = 8.6 Hz), 
 7.91–7.87 (m, 2H), 7.71 (td, 1H, J = 7.0 and 1.1 Hz), 7.49 (dd, 1H, J 
= 8.3 and 0.6 Hz), 7.45 (d, 1H, J = 9.1 Hz), 7.35 (td, 1H, J = 6.8 and 
1.1 Hz), 7.28 (td, 1H, J = 6.8 and 1.1 Hz), 7.10 (d, 1H, J = 8.6 Hz), 
3.78 (s, 3H) ppm. 
13
C NMR (125 MHz, CDCl3):  158.1, 155.4, 
151.0, 133.9, 132.6, 132.4, 131.4, 129.2, 128.2, 127.6, 127.3, 126.8, 
126.6, 126.4, 124.7, 124.0, 118.7, 113.5, 56.8 ppm. HRMS (EI) calcd. 
for C19H14N2O (M
+
) 286.1106. Found 286.1104.  
 BBr3 (1.2 eq.) was carefully added to a solution of 1-(2-
methoxynaphthalen-1-yl)phthalazine (2.97 mmol, 850 mg) in anhy-
drous CH2Cl2 (12 mL) under argon. The reaction mixture was re-
fluxed for 1 hour and stirred overnight at room temperature. The 
resulting mixture was cooled to 0 C, quenched with H2O, and the 
formed precipitated was vigorously stirred in a CH2Cl2/Na2CO3 (2M, 
aq.) mixture. The organic phase was separated and the aqueous layer 
was extracted with CH2Cl2. The combined organic layer was dried 
(MgSO4), filtered, concentrated, and the residue was purified by 
column chromatography on silica gel (CH2Cl2/MeOH 50:2 Et3N 1%) 
to afford 3 (646 mg, 80%) as a brown solid.
 1
H NMR ((CD3)2SO, 500 
MHz):  9.91 (br s, 1H), 9.78 (s, 1H), 8.27 (d, 1H, J = 8.1 Hz), 8.02–
7.99 (m, 2H), 7.92 (d, 1H, J = 7.8 Hz), 7.85 (t, 1H, J = 8.1 Hz), 7.42 
(d, 1H, J = 8.8 Hz), 7.40 (d, 1H, J = 9.0 Hz), 7.30 (td, 1H, J = 7.5 and 
1.0 Hz), 7.25 (td, 1H, J = 7.7 and 1.3 Hz), 6.90 (d, 1H, J = 8.4 Hz) 
ppm. 
13
C NMR ((CD3)2SO, 125 MHz):  157.5, 153.2, 150.7, 133.6, 
133.0, 132.6, 130.6, 128.1, 127.8, 126.8, 126.7, 126.4, 126.2, 125.5, 
123.6, 122.9, 118.2, 115.1 ppm. HRMS (EI) calcd. for C18H12N2O 
(M
+
) 272.0950. Found 272.0947. 
 General Procedure for the Synthesis of nonaflates 5-6. Follow-
ing a described procedure,
46
 over a suspension of the corresponding 
alcohol (1.0 equiv) and K2CO3 (1.5 equiv) in acetonitrile (0.5 M), 
perfluorobutanesulfonyl fluoride (90%, 1.2 equiv) was added in one 
portion, and the resulting mixture was vigorously stirred for 24 h. 
After completion (TLC monitoring), the reaction mixture was filtered 
through a Celite pad, the solvent was removed in vacuum, and the 
residue was purified by flash column chromatography over silica gel. 
 Compound 5. Following the general procedure starting from 2 
(1.43 mmol, 390 mg),
47
 purification by flash chromatography 
(EtOAc/n-hexane 2:1) gave ()-5 (708 mg, 90%) as a light yellow 
solid. 
1
H NMR (400 MHz, CDCl3): δ 9.55 (s, 1H), 8.21 (d, 1H, J = 
8.4 Hz), 8.15 (d, 1H, J = 9.1 Hz), 8.02 (d, 1H, J = 8.2 Hz), 7.96 (t, 
1H, J = 8.0 Hz), 7.65–7.58 (m, 2H), 7.53 (t, 1H, J = 8.0 Hz), 7.47–
7.43 (m, 2H), 7.27 (d, 1H, J = 8.0 Hz) ppm. 
13
C NMR (100 MHz, 
CDCl3): δ 163.3, 154.8, 150.6, 144.6, 134.5, 132.4, 132.3, 132.1, 
129.0, 128.4, 128.3, 128.3, 127.5, 126.9, 126.4, 125.9, 125.0, 119.4 
ppm, (nonaflate group not observed). 
19
F NMR (377 MHz, CDCl3): 
80.7 (t, J = 11 Hz), 110.0 (q, J = 15 Hz), 121.1 (m), 126.0 (m) 
ppm. HRMS (ESI) calcd. for C22H12F9N2O3S (M+H
+
) 555.0419. 
Found 555.0412. 
 Compound 6. Following the general procedure starting from 3 
(3.9 mmol, 1.07 g), purification by flash chromatography 
(CH2Cl2/MeOH 50:1) gave ()-6 (1.2 g, 56%) as a light yellow solid. 
1
H NMR (400 MHz, CDCl3): δ 9.70 (s, 1H), 8.16 (d, 1H, J = 9.1 Hz), 
8.11 (d, 1H, J = 8.1 Hz), 8.02 (d, 1H, J = 8.2 Hz), 7.96 (t, 1H, J = 7.6 
Hz), 7.78 (t, 1H, J = 7.6 Hz), 7.64 (d, 1H, J = 9.2 Hz), 7.59 (t, 1H, J = 
7.6 Hz), 7.47–7.41 (m, 2H), 7.28 (d, 1H, J = 8.8 Hz) ppm. 13C NMR 
(100 MHz, CDCl3): δ 154.8, 151.4, 145.2, 133.0, 133.0, 132.9, 132.4, 
132.0, 128.3, 128.2, 127.4, 126.9, 126.7, 126.4, 126.2, 126.2, 125.6, 
119.5 ppm, (nonaflate group not observed). 
19
F NMR (377 MHz, 
CDCl3): 80.7 (t, J = 11 Hz), 110.0 (t, J = 15 Hz), 121.2 (m), 
126.0 (m) ppm. HRMS (ESI) calcd. for C22H12F9N2O3S (M+H
+
): 
555.0419. Found: 555.0414. 
 General Procedure for the Synthesis of 7–10. A flamed-dried 
Schlenk tube was charged with the corresponding nonaflate 4-6 (0.2 
mmol), Cs2CO3 (0.4 mmol, 130.2 mg), Pd(dba)2 (10 mol%, 11.6 mg) 
and BINAP (10 mol%, 12.4 mg). After three cycles of vacuum-argon 
flushing, deoxygenated dry toluene (4 mL) and the appropriate amine 
(0.4 mmol) were sequentially added in this order. The reaction mix-
ture was stirred at 60C for 24 hours, then cooled down to room 
temperature, and filtered through a Celite pad. The solvent was re-
moved under vacuum and the resulting residue was purified by col-
umn chromatography on silica gel. 
 Compound 7. Following the general procedure starting from 4; 
purification by flash chromatography (CH2Cl2/EtOAc 50:110:1) 
gave 7 (55 mg, 80%) as a yellow foam. 
1
H NMR (400 MHz, CDCl3): 
 8.78 (d, 1H, J = 5.8 Hz), 7.93 (d, 1H, J = 8.3 Hz), 7.88 (d, 1H, J = 
9.0 Hz), 7.83 (d, 1H, J = 8.0 Hz), 7.78 (dd, 1H, J = 5.7 and 0.6 Hz), 
7.68 (ddd, 1H, J = 8.2, 6.9, and 1.2 Hz), 7.71 (d, 1H, J = 9.0 Hz), 7.60 
(dd, 1H, J = 8.5 and 0.8 Hz), 7.39 (ddd, 1H, J = 8.4, 7.0, and 1.2 Hz), 
7.30 (ddd, 1H, J = 8.1, 6.9, and 1.2 Hz), 7.23–7.16 (m, 3H), 7.02–6.97 
(m, 2H), 6.95–6.91 (m, 1H), 6.88 (t, 1H, J = 7.3 Hz), 6.05 (s, 1H) 
ppm. 
13
C NMR (100 MHz, CDCl3):  158.6, 143.1, 142.9, 139.4, 
136.9, 134.0, 130.7, 129.7, 129.4, 129.3, 128.6, 128.2, 127.8, 127.5, 
127.2, 126.7, 124.9, 123.5, 121.9, 121.4, 120.7, 119.1, 118.8 ppm. 
HRMS (ESI) calcd. C25H19N2 for (M+H
+
) 347.1543. Found 347.1537.  
 Compound 8. Following the general procedure starting from 5; 
purification by flash chromatography (n-hexane/EtOAc 3:1) gave 8 
(69 mg, 99%) as a yellow foam. 
1
H NMR (400 MHz, CDCl3):  9.45 
(s, 1H), 8.08 (d, 1H, J = 8.5 Hz), 7.91 (d, 1H, J = 9.0 Hz), 7.86 (ddd, 
1H, J = 8.5, 6.9, and 1.4 Hz), 7.84 (d, 1H, J = 8.0 Hz), 7.71 (d, 1H, J 
= 9.1 Hz), 7.66–7.59 (m, 1H), 7.44 (ddd, 1H, J = 8.3, 7.0, and 1.1 
Hz), 7.33 (ddd, 1H, J = 8.0, 6.9, and 1.1 Hz), 7.27–7.17 (m, 3H), 
7.07–7.01 (m, 2H), 6.97 (d, 1H, J = 8.5 Hz), 6.92 (t, 1H, J = 1.0 Hz), 
6.47 (br s, 1H) ppm. 
13
C NMR (100 MHz, CDCl3):  167.7, 155.1, 
150.9, 142.3, 139.5, 134.4, 133.1, 130.6, 129.3, 129.1, 128.9, 128.2, 
128.1, 127.1, 127.0, 125.0, 124.3, 123.8, 121.7, 119.2, 119.1, 118.9 
ppm. HRMS (ESI) calcd. for C24H18N3 (M+H
+
) 348.1495. Found 
348.1500.  
 Compound 9. Following the general procedure starting from 6; 
purification by flash chromatography (n-hexane/EtOAc 3:1) gave 9 
(41 mg, 59%) as a yellow amorphous solid. 
1
H NMR (400 MHz, 
CDCl3):  9.63 (s, 1H), 8.05 (d, 1H, J = 8.1 Hz), 7.95–7.86 (m, 2H), 
7.85 (d, 1H, J = 8.1 Hz), 7.73 (d, 1H, J = 9.1 Hz), 7.69 (t, 1H, J = 7.3 
Hz), 7.55 (d, 1H, J = 8.3 Hz), 7.32 (t, 1H, J = 7.3 Hz), 7.25–7.13 (m, 
3H), 6.99 (d, 2H, J = 7.8 Hz), 6.93 (d, 1H, J = 8.5 Hz), 6.88 (t, 1H, J 
= 7.3 Hz), 6.37 (br s, 1H) ppm. 
13
C NMR (100 MHz, CDCl3):  158.7, 
151.1, 142.5, 139.8, 133.7, 132.8, 130.3, 129.2, 128.1, 127.0, 126.9, 
126.8, 126.6, 126.2, 124.5, 123.7, 121.4, 119.3, 118.6, 118.5 ppm. 
HRMS (ESI) calcd. for C24H18N3 (M+H
+
) 348.1495. Found 348.1491. 
 Compound 10. Following the general procedure starting from 4; 
purification by flash chromatography (toluene/EtOAc 10:1) gave 10 
(59 mg, 79%) as a light yellow foam. 
1
H NMR (400 MHz, CDCl3):  
8.78 (d, 1H, J = 5.7 Hz), 7.94 (d, 1H, J = 8.3 Hz), 7.83 (d, 1H, J = 9.1 
Hz), 7.80 (m, 2H), 7.70 (ddd, 1H, J = 8.0, 6.9, and 1.1 Hz), 7.64 (d, 
1H, J = 8.3 Hz), 7.49 (d, 1H, J = 9.1 Hz), 7.42 (ddd, 1H, J = 8.2, 7.0, 
and 1.0 Hz), 7.28–7.22 (m, 1H), 7.18 (ddd, 1H, J = 8.2, 6.9, and 1.3 
Hz), 7.03–6.95 (m, 2H), 6.88 (d, 1H, J = 8.4 Hz), 6.82–6.75 (m, 2H), 
5.76 (br s, 1H), 3.75 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3):  
158.6, 155.6, 142.8, 141.4, 137.1, 135.7, 134.0, 131.0, 129.9, 128.7, 
128.2, 127.9, 127.7, 127.2, 126.8, 124.5, 123.0, 120.8, 119.1, 117.8, 
114.7, 55.7 ppm. HRMS (ESI) calcd. for C26H21N2O (M+H
+
) 
377.1648. Found 377.1641.  
  General procedure for the synthesis of 11–17. A dried Schlenk 
tube was charged with the substrate 1–3 or 7–10 (0.1–0.2 mmol) and 
BPh3 (1 equiv.). After three cycles of vacuum-argon flushing 1 mL of 
dried-deoxygenated toluene was added. The reaction mixture was 
stirred at 90 C until reaching maximum consumption of the starting 
material (TLC monitoring), then cooled down to room temperature, 
and finally concentrated to dryness. The crude products were purified 
by column chromatography on silica gel (n-hexane/EtOAc, tolu-
ene/EtOAc or CH2Cl2/EtOAc mixtures as eluents) or by washing with 
n-hexane/EtOAc mixtures. 
 Compound 11. Following the general procedure starting from 1 
(0.1 mmol, 27 mg) and heating for 18 hours; flash chromatography on 
silica gel (n-hexane/EtOAc 1:3) gave 11 (43 mg, 99%) as a yellow 
foam. 
1
H NMR (400 MHz, CDCl3):  8.05 (d, 1H, J = 5.6 Hz), 7.94–
7.88 (m, 3H), 7.83 (t, 1H, J = 7.8 Hz), 7.73 (d, 1H, J = 8.8 Hz), 7.65 
(d, 1H, J = 6.6 Hz), 7.48 (d, 1H, J = 8.8 Hz), 7.45 (t, 1H, J = 8.2 Hz), 
7.39–7.37 (m, 2H), 7.32–7.25 (m, 7H), 7.14 (ddd, 1H, J = 8.6, 6.6, 
and 1.2 Hz), 7.04 (t, 2H, J = 7.0 Hz), 6.97 (t, 1H, J = 7.0 Hz) ppm. 
13
C NMR (100 MHz, CDCl3):  163.4, 151.5, 137.6, 136.1, 134.9, 
134.4, 132.9, 132.3, 131.9, 131.0, 128.5, 128.4, 127.7, 127.6, 127.0, 
126.9, 126.7, 126.1, 125.5, 125.1, 124.7, 123.3, 121.7, 119.6, 113.8 
ppm, (C–B not observed). 11B NMR (128 MHz, CDCl3):  6.1 (br s) 
ppm. HRMS (ESI) calcd. for C31H23BNO (M+H
+
) 436.1867. Found 
436.1847. 
 Compound 12. Following the general procedure starting from 2 
(0.2 mmol, 54 mg) and heating for 20 hours; the reaction crude was 
triturated with a n-hexane/EtOAc 3:1 mixture to give 12 (88 mg, 
99%) as a yellow-orange foam. 
1
H NMR (400 MHz, CDCl3):  8.82 
(s, 1H), 8.11 (d, 1H, J = 8.2 Hz), 7.99 (ddd, 1H, J = 8.2, 6.9, and 1.2 
Hz), 7.97 (d, 1H, J = 9.0 Hz), 7.93 (d, 1H, J = 8.6 Hz), 7.74 (d, 1H, J 
= 7.6 Hz), 7.49 (ddd, 1H, J = 8.2, 7.0, and 1.1 Hz), 7.46 (d, 1H, J = 
8.9 Hz), 7.42–7.38 (m, 3H), 7.34-7.29 (m, 4H), 7.24–7.21 (m, 3H), 
7.08 (t, 2H, J = 7.0 Hz), 7.02 (t, 1H, J = 7.2 Hz) ppm. 
13
C NMR (100 
MHz, CDCl3):  165.8, 155.9, 150.6, 147.9, 137.7, 136.2, 134.3, 
132.1, 131.8, 130.1, 128.9, 128.7, 128.6, 128.1, 127.8, 127.4, 126.9, 
125.9, 124.7, 124.3, 121.8, 119.8, 112.5 ppm, (C–B not observed). 
11
B NMR (128 MHz, CDCl3):  5.5 (br s) ppm. HRMS (ESI) calcd. 
for C30H22BN2O (M+H
+
) 437.1820. Found 437.1799. 
 Compound 13. Following the general procedure starting from 3 
(0.2 mmol, 54 mg) and heating for 48 hours, still starting material was 
remaining. Flash chromatography on silica gel (n-hexane/EtOAc 
2:11:1) gave 13 (40 mg, 48%) as a yellow foam. 1H NMR (400 
MHz, CDCl3):  9.30 (s, 1H), 8.07–8.03 (m, 2H), 7.99 (d, 1H, J = 9.0 
Hz), 7.96 (d, 1H, J = 8.9 Hz), 7.78–7.74 (m, 2H), 7.54 (d, 1H, J = 8.9 
Hz), 7.44 (d, 2H, J = 6.7 Hz), 7.36 (d, 2H, J = 6.2 Hz), 7.30–7.21 (m, 
5H), 7.16 (ddd, 1H, J = 8.2, 6.8, and 1.2 Hz), 7.08 (t, 2H, J = 7.4 Hz), 
7.01 (t, 1H, J = 7.2 Hz) ppm. 
13
C NMR (100 MHz, CDCl3):  164.2, 
151.1, 148.4, 136.3, 134.7, 133.9, 132.5, 132.4, 131.6, 130.0, 128.8, 
128.6, 127.5, 127.0, 126.8, 126.7, 126.5, 125.7, 125.6, 124.2, 123.7, 
122.0, 110.8 ppm, (C–B not observed). 11B NMR (128 MHz, CDCl3): 
 6.1 (br s) ppm. HRMS (ESI) calcd. for C30H22BN2O (M+H
+
) 
437.1820. Found 437.1801. 
 Compound 14. Following the general procedure starting from 7 
(0.1 mmol, 34.6 mg) and heating for 7 hours; flash chromatography 
on silica gel (n-hexane/EtOAc 3:1) gave 14 (44 mg, 86%) as a deep 
red foam. 
1
H NMR (400 MHz, CDCl3):  8.00 (d, 1H, J = 6.7 Hz), 
7.92 (d, 1H, J = 8.6 Hz), 7.87 (d, 1H, J = 8.0 Hz), 7.75 (t, 1H, J = 7.8 
Hz), 7.63 (d, 1H, J = 9.2 Hz), 7.61 (d, 1H, J = 8.0 Hz), 7.52 (d, 1H, J 
= 6.7 Hz), 7.38 (ddd, 1H, J = 8.3 6.9 and 1.0 Hz), 7.32 (d, 1H, J = 9.2 
Hz), 7.28–7.26 (m, 2H), 7.20–7.15 (m, 4H), 7.13 (ddd, 1H, J = 7.9, 
6.9 and 1.2 Hz), 7.08–6.91 (m, 9H), 6.81–6.80 (m, 2H) ppm. 13C 
NMR (100 MHz, CDCl3):  153.4, 151.2, 147.5, 136.9, 136.3, 133.3, 
133.1, 132.7, 132.1, 131.4, 129.2, 128.0, 127.9, 127.3, 126.8, 126.6, 
126.0, 125.5, 125.1, 125.0, 123.0, 122.6, 121.1, 117.9, 113.2 ppm, 
(C–B not observed). 11B NMR (128 MHz, CDCl3):  3.8 (br s) ppm. 
HRMS (ESI) calcd. for C37H28BN2 (M+H
+
) 511.2340. Found 
511.2325. 
 Compound 15. Following the general procedure starting from 8 
(0.1 mmol, 34.7 mg) and heating for 12 hours; flash chromatography 
on silica gel (toluene) gave 15 (48 mg, 94%) as a purple foam. 
1
H 
NMR (400 MHz, CDCl3):  8.75 (s, 1H), 8.00 (d, 1H, J = 8.0 Hz), 
7.89 (d, 1H, J = 8.5 Hz), 7.85 (ddd, 1H, J = 8.3, 7.0, and 1.2 Hz), 7.65 
(d, 1H, J = 9.3 Hz), 7.61 (d, 1H, J = 7.9 Hz), 7.37 (ddd, 1H, J = 8.3, 
7.1, and 1.1 Hz), 7.29–7.17 (m, 8H), 7.09–6.93 (m, 9H), 6.90–6.88 
(m, 2H) ppm. 
13
C NMR (100 MHz, CDCl3):  155.1, 153.5, 149.2, 
147.9, 146.3, 135.4, 134.7, 133.1, 133.0, 130.2, 129.2, 128.5, 128.2, 
128.1, 127.5, 127.4, 127.0, 126.8, 126.7, 126.4, 125.4, 125.3, 124.3, 
123.8, 120.6, 120.2, 111.3 ppm, (C–B not observed). 11B NMR (128 
MHz, CDCl3):  2.9 (br s) ppm. HRMS (ESI) calcd. for C37H27BN3 
(M+H
+
) 512.2293. Found 512.2276. 
 Compound 16. Following the general procedure starting from 13 
(0.1 mmol, 34.7 mg), and heating for 72 hours, still starting material 
was remaining. Flash chromatography on silica gel (n-hexane/EtOAc 
3:1) gave 16 (20 mg, 39%) as a purple foam. 
1
H NMR (400 MHz, 
CDCl3):  9.16 (d, 1H, J = 0.8 Hz), 7.99 (d, 1H, J = 8.2 Hz), 7.98 (dd, 
1H, J = 7.5 and 1.4 Hz), 7.92 (ddd, 1H, J = 8.0, 7.0, and 1.0 Hz), 
7.69–7.63 (m, 3H), 7.46–7.44 (m, 2H), 7.29 (d, 1H, J = 9.2 Hz), 7.17 
(ddd, 1H, J = 8.0, 6.8, and 1.2 Hz), 7.10–7.05 (m, 4H), 7.03–6.91 (m, 
11H) ppm. 
13
C NMR (100 MHz, CDCl3):  153.9, 148.8, 147.1, 
147.0, 135.9, 133.9, 133.6, 133.4, 132.8, 132.0, 130.2, 128.2, 128.0, 
127.5, 127.2, 126.6, 126.4, 126.3, 126.2, 125.3, 125.2, 124.6, 123.6, 
123.1, 121.1, 109.3 ppm, (C–B not observed). 11B NMR (128 MHz, 
CDCl3):  4.0 (br s) ppm. HRMS (ESI) calcd. for C37H26BN3Na 
(M+Na
+
) 534.2112. Found 534.2102. 
 Compound 17. Following the general procedure starting from 10 
(0.1 mmol, 37.6 mg) and heating for 12 hours; flash chromatography 
on silica gel (n-hexane/CH2Cl2 1:3) gave 17 (37 mg, 69%) as a purple 
foam. 
1
H NMR (400 MHz, CDCl3):  7.98 (d, 1H, J = 6.7 Hz), 7.91 
(d, 1H, J = 8.7 Hz), 7.86 (d, 1H, J = 8.1 Hz), 7.73 (t, 1H, J = 7.9 Hz), 
7.62 (d, 1H, J = 9.2 Hz), 7.60 (d, 1H, J = 7.8 Hz), 7.50 (d, 1H, J = 6.7 
Hz), 7.36 (t, 1H, J = 8.1 Hz), 7.28–7.24 (m, 3H), 7.13–6.93 (m, 12H), 
7.50 (d, 2H, J = 8.8 Hz), 6.48 (dd, 1H, J = 8.8 and 2.8 Hz), 3.72 (s, 
3H) ppm. 
13
C NMR (100 MHz, CDCl3):  155.6, 153.7, 151.0, 140.8, 
136.9, 136.2, 133.4, 133.2, 132.7, 132.0, 131.4, 129.9, 128.2, 127.9, 
127.2, 127.1, 126.8, 126.6, 126.0, 125.9, 125.4, 125.1, 125.0, 122.5, 
121.0, 117.7, 113.7, 112.9, 112.6, 55.3 ppm, (C–B not observed). 11B 
NMR (128 MHz, CDCl3):  3.7 (br s) ppm. HRMS (ESI) calcd. for 
C38H30BN2O (M+H
+
) 541.2446. Found 541.2435. 
Photophysical Measurements. The photophysical data were ob-
tained for air-equilibrated solutions at room temperature. The 
UV/Vis-absorption spectra and the fluorescence spectra were record-
ed with standard instrumentation. The emission spectra were correct-
ed for the sensitivity of the photomultiplier detector. The fluorescence 
quantum yields were determined with 4-amino-N-propyl-1,8-
naphthalimide (Φfluo = 0.48 in acetonitrile)
31
 or tris(2,2′-
bipyridyl)dichlororuthenium(II) hexahydrate (Φfluo = 0.028 in aerated 
water)
48
 as reference and corrected for refractive index differences of 
the used solvents. The lifetime measurements were performed by 
means of time-correlated single-photon-counting with picosecond 
 pulsed diode laser (λ = 442 nm, pulse width fwhm 78 ps, λ = 482 nm, 
pulse width fwhm 101 ps) as excitation sources. 
Confocal Fluorescence Microscopy. N13 mouse microglia cells 
were grown to 60% confluence on 8 well slides in complete medium 
(CM) containing Roswell Park Memorial Institute 1640 medium 
supplemented with 10% fetal calf serum, penicillin (100 units mL
–1
), 
streptomycin (100 µg mL
–1
), and gentamicin (1.25 units mL
–1
). Test 
compounds were diluted in fresh CM, added to each well and cultured 
under optimal conditions (37 ºC and 5% CO2 in a humidified incuba-
tor) for a further 24 hours. Live cells were examined using a micro-
scope stage-top incubator to maintain cells under optimal conditions 
(37 ºC, 5% CO2 and humidity) during imaging. Co-staining, using the 
lipophilic marker FM4-64FX, was achieved by adding it directly to 
the culture medium at a 5 μg/mL final concentration. For fixation, 
cells were washed with pre-warmed PBS, incubated with 4% para-
formaldehyde in phosphate buffer saline (PBS) for 20 minutes at 
room temperature and washed three times with PBS. Sub-membrane 
actin and nuclei (DNA) were labelled for 20 minutes with 0.1 µM 
Atto488-conjugated Phalloidin and 8 µM Hoechst 33342, respective-
ly. Live and fixed cells were analyzed using an inverted microscope, a 
25x NA 0.95 Plan-APO water immersion objective, and a laser scan-
ning confocal system. In live cells, the emission of the organoboron 
dyes and FM4-64FX were detected using 561 and 594 nm excitation 
wavelengths with 569–635 and 712–774 nm detection windows, 
respectively. In fixed cells Hoechst 33258, ATTO488-Phalloidin and 
the organoboron dyes were detected using 405, 488 and 561 nm 
excitation wavelengths with 415–470, 493–555 and 668–690 nm 
detection windows, respectively. Channels were acquired sequentially 
and configured to avoid crosstalk between different fluorophores. 
ASSOCIATED CONTENT  
Supporting Information. Copies of 1H and 13C NMR spectra, 
details on DFT calculations, additional photophysical data. This 
material is available free of charge via the Internet at 
http://pubs.acs.org. 
AUTHOR INFORMATION 
Corresponding Author 
* E-mail (U.P.): uwe.pischel@diq.uhu.es 
* E-mail (A.R.): abel.ros@iiq.csic.es 
Notes 
The authors declare no competing financial interest. 
ACKNOWLEDGEMENTS 
The funding by the Spanish Ministry of Economy and Competi-
tiveness (grants CTQ2014-54729-C2-1-P for U.P., CTQ2013-
48164-C2-1-P, CTQ2013-48164-C2-2-P for A.R., CTQ2013-
41339-P and CTQ2015-71896-REDT for E.P.I., Ramón y Cajal 
contract RYC-2013-12585 for A.R.), the European Union 
(FEDER), and the Andalusian Government (grants 2012/FQM-
2140 for U.P., 2009/FQM-4537 and 2012/FQM-1078 for A.R., 
postdoctoral contract for V.F.P.) is acknowledged. Furthermore, 
we are thankful for the provided access to the Supercomputing 
and Bioinformatics Center (University of Málaga). 
REFERENCES 
(1) Wakamiya, A.; Taniguchi, T.; Yamaguchi, S. Angew. 
Chem. Int. Ed. 2006, 45, 3170-3173. 
(2) Entwistle, C. D.; Marder, T. B. Angew. Chem. Int. Ed. 
2002, 41, 2927-2931. 
(3) Rao, Y.-L.; Wang, S. Inorg. Chem. 2011, 50, 12263-12274. 
(4) Bozdemir, O. A.; Guliyev, R.; Buyukcakir, O.; Selcuk, S.; 
Kolemen, S.; Gulseren, G.; Nalbantoglu, T.; Boyaci, H.; Akkaya, E. 
U. J. Am. Chem. Soc. 2010, 132, 8029-8036. 
(5) Kowada, T.; Maeda, H.; Kikuchi, K. Chem. Soc. Rev. 2015, 
44, 4953-4972. 
(6) Rao, Y.-L.; Amarne, H.; Zhao, S.-B.; McCormick, T. M.; 
Martić, S.; Sun, Y.; Wang, R.-Y.; Wang, S. J. Am. Chem. Soc. 2008, 
130, 12898-12900. 
(7) Baik, C.; Hudson, Z. M.; Amarne, H.; Wang, S. J. Am. 
Chem. Soc. 2009, 131, 14549-14559. 
(8) Kolemen, S.; Işık, M.; Kim, G. M.; Kim, D.; Geng, H.; 
Buyuktemiz, M.; Karatas, T.; Zhang, X.-F.; Dede, Y.; Yoon, J.; Ak-
kaya, E. U. Angew. Chem. Int. Ed. 2015, 54, 5340-5344. 
(9) Lavis, L. D.; Raines, R. T. ACS Chem. Biol. 2014, 9, 855-
866. 
(10) Pais, V. F.; Alcaide, M. M.; Rodríguez-López, R.; Collado, 
D.; Nájera, F.; Pérez-Inestrosa, E.; Álvarez, E.; Lassaletta, J. M.; 
Fernández, R.; Ros, A.; Pischel, U. Chem. Eur. J. 2015, 21, 15369-
15376. 
(11) Frath, D.; Massue, J.; Ulrich, G.; Ziessel, R. Angew. Chem. 
Int. Ed. 2014, 53, 2290-2310. 
(12) Frath, D.; Azizi, S.; Ulrich, G.; Retailleau, P.; Ziessel, R. 
Org. Lett. 2011, 13, 3414-3417. 
(13) Frath, D.; Poirel, A.; Ulrich, G.; De Nicola, A.; Ziessel, R. 
Chem. Commun. 2013, 49, 4908-4910. 
(14) Coskun, A.; Akkaya, E. U. J. Am. Chem. Soc. 2006, 128, 
14474-14475. 
(15) Loudet, A.; Burgess, K. Chem. Rev. 2007, 107, 4891-4932. 
(16) Zheng, Q.; Xu, G.; Prasad, P. N. Chem. Eur. J. 2008, 14, 
5812-5819. 
(17) Ulrich, G.; Ziessel, R.; Harriman, A. Angew. Chem. Int. Ed. 
2008, 47, 1184-1201. 
(18) Juárez, L. A.; Barba-Bon, A.; Costero, A. M.; Martínez-
Máñez, R.; Sancenón, F.; Parra, M.; Gaviña, P.; Terencio, M. C.; 
Alcaraz, M. J. Chem. Eur. J. 2015, 21, 15486-15490. 
(19) Juárez, L. A.; Costero, A. M.; Parra, M.; Gil, S.; Sancenón, 
F.; Martínez-Máñez, R. Chem. Commun. 2015, 51, 1725-1727. 
(20) Lu, H.; Mack, J.; Yang, Y.; Shen, Z. Chem. Soc. Rev. 2014, 
43, 4778-4823. 
(21) Rurack, K.; Kollmannsberger, M.; Daub, J. Angew. Chem. 
Int. Ed. 2001, 40, 385-387. 
(22) Killoran, J.; Allen, L.; Gallagher, J. F.; Gallagher, W. M.; 
O’Shea, D. F. Chem. Commun. 2002, 1862-1863. 
(23) Loudet, A.; Bandichhor, R.; Burgess, K.; Palma, A.; 
McDonnell, S. O.; Hall, M. J.; O’Shea, D. F. Org. Lett. 2008, 10, 
4771-4774. 
(24) Le Guennic, B.; Maury, O.; Jacquemin, D. Phys. Chem. 
Chem. Phys. 2012, 14, 157-164. 
(25) Koide, Y.; Urano, Y.; Hanaoka, K.; Piao, W.; Kusakabe, 
M.; Saito, N.; Terai, T.; Okabe, T.; Nagano, T. J. Am. Chem. Soc. 
2012, 134, 5029-5031. 
(26) Grimm, J. B.; Sung, A. J.; Legant, W. R.; Hulamm, P.; 
Matlosz, S. M.; Betzig, E.; Lavis, L. D. ACS Chem. Biol. 2013, 8, 
1303-1310. 
(27) Kushida, Y.; Nagano, T.; Hanaoka, K. Analyst 2015, 140, 
685-695. 
(28) Yang, Y.; Lowry, M.; Xu, X.; Escobedo, J. O.; Sibrian-
Vazquez, M.; Wong, L.; Schowalter, C. M.; Jensen, T. J.; Fronczek, 
F. R.; Warner, I. M.; Strongin, R. M. Proc. Natl. Acad. Sci. U.S.A. 
2008, 105, 8829-8834. 
(29) Stennett, E. M. S.; Ciuba, M. A.; Levitus, M. Chem. Soc. 
Rev. 2014, 43, 1057-1075. 
(30) Zheng, Q.; Juette, M. F.; Jockusch, S.; Wasserman, M. R.; 
Zhou, Z.; Altman, R. B.; Blanchard, S. C. Chem. Soc. Rev. 2014, 43, 
1044-1056. 
(31) Santos, F. M. F.; Rosa, J. N.; Candeias, N. R.; Carvalho, C. 
P.; Matos, A. I.; Ventura, A. E.; Florindo, H. F.; Silva, L. C.; Pischel, 
U.; Gois, P. M. P. Chem. Eur. J. 2016, 22, 1631-1637. 
 (32) Guram, A. S.; Buchwald, S. L. J. Am. Chem. Soc. 1994, 
116, 7901-7902. 
(33) Paul, F.; Patt, J.; Hartwig, J. F. J. Am. Chem. Soc. 1994, 
116, 5969-5970. 
(34) Lippert, E. Z. Naturforsch. A 1955, 10, 541-545. 
(35) Mataga, N.; Kaifu, Y.; Koizumi, M. Bull. Chem. Soc. Jpn. 
1955, 28, 690-691. 
(36) Mataga, N.; Kaifu, Y.; Koizumi, M. Bull. Chem. Soc. Jpn. 
1956, 29, 465-470. 
(37) Casida, M. E. In Recent Advances in Density Functional 
Methods; Chong, D. P., Ed.; World Scientific: Singapore, 1995; Vol. 
1, p 155-192. 
(38) Pais, V. F.; Lassaletta, J. M.; Fernández, R.; El-Sheshtawy, 
H. S.; Ros, A.; Pischel, U. Chem. Eur. J. 2014, 20, 7638-7645. 
(39) Greenspan, P.; Fowler, S. D. J. Lipid Res. 1985, 26, 781-
789. 
(40) Sackett, D. L.; Wolff, J. Anal. Biochem. 1987, 167, 228-
234. 
(41) Belloc, F.; Dumain, P.; Boisseau, M. R.; Jalloustre, C.; Re-
iffers, J.; Bernard, P.; Lacombe, F. Cytometry 1994, 17, 59-64. 
(42) Gaffield, M. A.; Betz, W. J. Nat. Protocols 2007, 1, 2916-
2921. 
(43) Firdessa, R.; Oelschlaeger, T. A.; Moll, H. Eur. J. Cell. Bi-
ol. 2014, 93, 323-337. 
(44) Connolly, D. J.; Lacey, P. M.; McCarthy, M.; Saunders, C. 
P.; Carroll, A.-M.; Goddard, R.; Guiry, P. J. J. Org. Chem. 2004, 69, 
6572-6589. 
(45) Lim, C. W.; Tissot, O.; Mattison, A.; Hooper, M. W.; 
Brown, J. M.; Cowley, A. R.; Hulmes, D. I.; Blacker, A. J. Org. 
Process Res. Dev. 2003, 7, 379-384. 
(46) Ros, A.; Estepa, B.; Ramírez López, P.; Álvarez, E.; Fer-
nández, R.; Lassaletta, J. M. J. Am. Chem. Soc. 2013, 135, 15730-
15733. 
(47) Shekhar, S.; Dunn, T. B.; Kotecki, B. J.; Montavon, D. K.; 
Cullen, S. C. J. Org. Chem. 2011, 76, 4552-4563. 
(48) Nakamaru, K. Bull. Chem. Soc. Jpn. 1982, 55, 2697-2705.
 
TOC Graph 
 
 
